Therefore, suppression of myofibroblast-like transformation and induction of apoptotic death in activated HSCs upon MGP treatment may help alleviate chemical (both DMN and CCl4)-induced liver fibrosis in vivo. Here, MGP is linked to Hepatic fibrosis.